𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial

✍ Scribed by Joan Caballería; Albert Parés; Concepció Brú; José Mercader; Antonio Garcia Plaza; Llorenç Caballería; Gerardo Clemente; Luis Rodrigo; Joan Rodés

Book ID
118567975
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
112 KB
Volume
28
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind, randomized, placebo-cont
A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation
✍ Keith S. Henley; Michael R. Lucey; Daniel P. Normolle; Robert M. Merion; Ian D. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

A double-blind placebo-controlled trial of intravenous prostaglandin PGE, (40 pg/h) was conducted in adult orthotopic liver transplant recipients. Infusion was started intraoperatively and continued for up to 21 days. Patients were followed up for 180 days postoperatively. Among 172 patients eligibl

Rituximab in patients with primary progr
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
✍ Kathleen Hawker; Paul O'Connor; Mark S. Freedman; Peter A. Calabresi; Jack Antel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

## Abstract ## Objective Rituximab, a monoclonal antibody selectively depleting CD20+ B cells, has demonstrated efficacy in reducing disease activity in relapsing‐remitting multiple sclerosis (MS). We evaluated rituximab in adults with primary progressive MS (PPMS) through 96 weeks and safety thro